Finance

Beta
Lists
ALLO:NASDAQ
Allogene Therapeutics Inc
1,96 US$
+3,16%
(+0,060) 1D
1,96 US$
0,00% (0,00)
After hours
Closed: 21 მაი, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ALLO...
Open
1,88 US$
High
1,96 US$
Low
1,84 US$
Mkt. cap
676,50 მლნ.
Avg. vol.
13,98 მლნ.
Volume
4,33 მლნ.
52-wk high
4,46 US$
52-wk low
0,98 US$
EPS
-0,77 US$
Beta
0,46
Shares outstanding
345,16 მლნ.
No. of employees
150
News stories
From sources across the web
About Allogene Therapeutics Inc
CEO-
Employees150
Founded2017
HeadquartersSouth San Francisco, კალიფორნია, ამერიკის შეერთებული შტატები
Sector-
Websiteallogene.com
Last report
13 მაი. 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-0,18 US$ / -0,18 US$
0,00%miss
Revenue / Est. (USD)
- / 1,82 ათ.
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
ივნ. 2025
სექ. 2025
დეკ. 2025
მარ. 2026
Revenue
-
-
-
-
Cost of goods sold
40,16 მლნ.
31,16 მლნ.
28,63 მლნ.
32,00 მლნ.
Cost of revenue
40,16 მლნ.
31,16 მლნ.
28,63 მლნ.
32,00 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
14,28 მლნ.
13,74 მლნ.
13,77 მლნ.
14,09 მლნ.
Operating expense
14,28 მლნ.
13,74 მლნ.
13,77 მლნ.
14,09 მლნ.
Total operating expenses
54,44 მლნ.
44,90 მლნ.
42,40 მლნ.
46,09 მლნ.
Operating income
-54,44 მლნ.
-44,90 მლნ.
-42,40 მლნ.
-46,09 მლნ.
Other non operating income
-43,00 ათ.
-81,00 ათ.
247,00 ათ.
212,00 ათ.
EBT including unusual items
-50,94 მლნ.
-41,40 მლნ.
-38,81 მლნ.
-42,61 მლნ.
EBT excluding unusual items
-48,56 მლნ.
-41,40 მლნ.
-38,81 მლნ.
-42,61 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-50,94 მლნ.
-41,40 მლნ.
-38,81 მლნ.
-42,61 მლნ.
Net profit margin
-
-
-
-
Earnings per share
-0,22
-0,19
-0,17
-0,18
Interest and investment income
6,19 მლნ.
3,93 მლნ.
3,66 მლნ.
3,57 მლნ.
Interest expense
-268,00 ათ.
-344,00 ათ.
-313,00 ათ.
-300,00 ათ.
Net interest expenses
5,92 მლნ.
3,58 მლნ.
3,35 მლნ.
3,27 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-51,33 მლნ.
-41,80 მლნ.
-39,35 მლნ.
-43,22 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer